X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1956) 1956
Publication (420) 420
Book Review (217) 217
Book Chapter (8) 8
Conference Proceeding (3) 3
Book / eBook (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1813) 1813
animals (1212) 1212
humans (1210) 1210
sirtuin 1 - metabolism (868) 868
mice (719) 719
sirt1 (610) 610
sirtuin 1 - genetics (542) 542
male (510) 510
hormones, hormone substitutes, and hormone antagonists (482) 482
cell biology (478) 478
biochemistry & molecular biology (470) 470
sirtuin 1 - antagonists & inhibitors (452) 452
apoptosis (383) 383
sirtuins (371) 371
resveratrol (361) 361
oxidative stress (351) 351
acetylation (341) 341
sirtuins - metabolism (315) 315
proteins (303) 303
signal transduction (292) 292
expression (288) 288
calorie restriction (286) 286
metabolism (284) 284
article (282) 282
rats (278) 278
sirtuin 1 (276) 276
stilbenes - pharmacology (273) 273
cell line, tumor (269) 269
cells, cultured (266) 266
female (266) 266
endocrine system diseases (260) 260
cancer (253) 253
sirtuins - antagonists & inhibitors (253) 253
gene expression (247) 247
activation (246) 246
enzymes and coenzymes (237) 237
mice, inbred c57bl (237) 237
rodents (237) 237
cell line (234) 234
sirt1 protein (207) 207
food and beverages (206) 206
research (204) 204
physiological aspects (202) 202
signal transduction - drug effects (198) 198
apoptosis - drug effects (194) 194
inflammation (191) 191
multidisciplinary sciences (190) 190
nad (188) 188
analysis (179) 179
inhibition (177) 177
phosphorylation (177) 177
research article (174) 174
p53 (173) 173
deacetylase (172) 172
enzyme inhibitors - pharmacology (166) 166
sirtuins - genetics (166) 166
enzymes (164) 164
physiology (163) 163
histone deacetylase (162) 162
mice, knockout (160) 160
oncology (160) 160
life-span (159) 159
pharmacology & pharmacy (157) 157
transcription factors (155) 155
rna interference (153) 153
disease models, animal (152) 152
cells (149) 149
biological phenomena, cell phenomena, and immunity (147) 147
aging (146) 146
gene-expression (144) 144
tumor suppressor protein p53 - metabolism (140) 140
gene expression regulation (138) 138
transcription (138) 138
health aspects (134) 134
genetic aspects (133) 133
medicine (133) 133
kinases (132) 132
neurosciences (130) 130
rats, sprague-dawley (130) 130
endocrinology & metabolism (127) 127
biology (126) 126
disease (124) 124
nf-kappa-b (123) 123
protein (123) 123
mitochondria - metabolism (121) 121
protein binding (121) 121
reactive oxygen species - metabolism (121) 121
dose-response relationship, drug (120) 120
saccharomyces-cerevisiae (119) 119
sirtuin (119) 119
science (116) 116
cell proliferation - drug effects (114) 114
mitochondria (113) 113
sirtuin 1 - physiology (113) 113
down-regulation (111) 111
nad - metabolism (110) 110
sirtuin 2 - antagonists & inhibitors (110) 110
blotting, western (109) 109
chemistry, medicinal (107) 107
cell survival - drug effects (106) 106
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Metabolism, ISSN 1550-4131, 09/2013, Volume 18, Issue 3, pp. 416 - 430
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2004, Volume 279, Issue 26, pp. 26830 - 26838
Mutations in Sir Antagonist 1 ( SAN1 ) suppress defects in SIR4 and SPT16 in Saccharomyces cerevisiae . San1 contains a RING domain, suggesting that it... 
MATING-TYPE LOCI | YEAST | TRANSCRIPTIONAL STATES | CHROMATIN-STRUCTURE | SHUTTLE VECTORS | HISTONE H2B | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENE-EXPRESSION | SILENCING PROTEINS | CELL-CYCLE | SACCHAROMYCES-CEREVISIAE | Saccharomyces cerevisiae - genetics | Humans | Ubiquitin - metabolism | Molecular Sequence Data | Silent Information Regulator Proteins, Saccharomyces cerevisiae - genetics | Minichromosome Maintenance Complex Component 4 | DNA-Binding Proteins - metabolism | Saccharomyces cerevisiae - metabolism | Sirtuin 2 | Sirtuins - chemistry | Triticum - enzymology | Sirtuins - genetics | DNA, Ribosomal - genetics | Telomere - genetics | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Amino Acid Sequence | Gene Expression | Histone Deacetylases - genetics | Silent Information Regulator Proteins, Saccharomyces cerevisiae - chemistry | Silent Information Regulator Proteins, Saccharomyces cerevisiae - metabolism | Cell Cycle Proteins - metabolism | Gene Silencing | Histone Deacetylases - chemistry | Ubiquitin - chemistry | Ubiquitin-Protein Ligases - metabolism | Recombinant Proteins - chemistry | Histone Deacetylases - metabolism | Recombinant Proteins - genetics | Saccharomyces cerevisiae Proteins - genetics | Ubiquitin-Protein Ligases - chemistry | Saccharomyces cerevisiae - cytology | Saccharomyces cerevisiae Proteins - metabolism | Ubiquitin-Protein Ligases - genetics | Sirtuins - metabolism | Saccharomyces cerevisiae Proteins - chemistry | Index Medicus
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 06/2014, Volume 23, Issue 11, pp. 2995 - 3007
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 10/2010, Volume 30, Issue 20, pp. 4890 - 4900
Journal Article
Nature Neuroscience, ISSN 1097-6256, 08/2013, Volume 16, Issue 8, pp. 1008 - 1015
Journal Article
Molecular Nutrition & Food Research, ISSN 1613-4125, 08/2015, Volume 59, Issue 8, pp. 1443 - 1457
ScopeResveratrol (RSV), a natural polyphenol, has been reported to attenuate nonalcoholic fatty liver disease (NAFLD); however, its underlying mechanism is... 
NAFLD | Treatment | Hepatocyte | SIRT1 | Resveratrol | ACTIVATION | LIPID-METABOLISM | PROTEIN-KINASE | FOOD SCIENCE & TECHNOLOGY | NONALCOHOLIC FATTY LIVER | DIET | INFLAMMATION | DISEASE | AMPK | HEALTH | Sirtuin 1 - metabolism | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Stilbenes - therapeutic use | Antioxidants - metabolism | Humans | Stilbenes - metabolism | Mice, 129 Strain | Sirtuin 1 - genetics | Autophagy - drug effects | Fatty Acids, Nonesterified - metabolism | Liver - drug effects | RNA Interference | Enzyme Induction - drug effects | Sirtuin 1 - chemistry | Cyclic AMP - metabolism | Fatty Acids, Nonesterified - adverse effects | Microscopy, Electron, Transmission | Second Messenger Systems - drug effects | Liver - ultrastructure | Liver - metabolism | Enzyme Inhibitors - pharmacology | Non-alcoholic Fatty Liver Disease - metabolism | Adenylyl Cyclases - metabolism | Sirtuin 1 - antagonists & inhibitors | Hep G2 Cells | Cyclic AMP - antagonists & inhibitors | Antioxidants - therapeutic use | Animals | Adenylyl Cyclases - chemistry | Lipid Metabolism - drug effects | Fatty Acids, Nonesterified - antagonists & inhibitors | Cyclic AMP - agonists | Non-alcoholic Fatty Liver Disease - diet therapy | Adenylyl Cyclases - genetics | Dietary Supplements | Triglycerides | Liver diseases | Fatty acids | Liver | Index Medicus
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 02/2016, Volume 101, pp. 100 - 111
The thiazolidinedione pioglitazone, which is also a PPAR-γ agonist, now is widely used in patients with hypercholesterolemia and hypertriglyceridemia. NF-κB is... 
NF-κB p65 acetylation | Acute kidney injury | Cisplatin | PPAR-γ | PHOSPHORYLATION | P300 | PPAR-gamma | PROTECTS | ISCHEMIA-REPERFUSION INJURY | INHIBITION | INFLAMMATION | NF-kappa B p65 acetylation | AMPK | PHARMACOLOGY & PHARMACY | ACCUMULATION | DYSFUNCTION | EXPRESSION | Sirtuin 1 - metabolism | AMP-Activated Protein Kinases - metabolism | Kidney - pathology | Transcription Factor RelA - antagonists & inhibitors | E1A-Associated p300 Protein - genetics | Male | E1A-Associated p300 Protein - metabolism | Protein Transport - drug effects | Protective Agents - therapeutic use | PPAR gamma - metabolism | Thiazolidinediones - administration & dosage | Sirtuin 1 - genetics | Dose-Response Relationship, Drug | Kidney - metabolism | Thiazolidinediones - therapeutic use | Protein Processing, Post-Translational - drug effects | Antineoplastic Agents - adverse effects | E1A-Associated p300 Protein - antagonists & inhibitors | Acute Kidney Injury - chemically induced | Cisplatin - antagonists & inhibitors | Phosphorylation - drug effects | Kidney - drug effects | Acute Kidney Injury - pathology | AMP-Activated Protein Kinases - antagonists & inhibitors | Mice, Inbred C57BL | Antineoplastic Agents - chemistry | Sirtuin 1 - antagonists & inhibitors | Acute Kidney Injury - prevention & control | Gene Expression Regulation - drug effects | Acetylation - drug effects | Animals | Signal Transduction - drug effects | Transcription Factor RelA - metabolism | PPAR gamma - agonists | Survival Analysis | Cisplatin - adverse effects | Protective Agents - administration & dosage | Acute Kidney Injury - metabolism | AMP-Activated Protein Kinases - genetics | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 01/2015, Volume 125, Issue 4, pp. 710 - 719
The precise mechanism for reduced thrombosis in prekallikrein null mice (Klkb1(-/-)) is unknown. Klkb1(-/-) mice have delayed carotid artery occlusion times on... 
PLASMA KALLIKREIN | MOLECULAR-WEIGHT KININOGEN | ENDOTHELIAL-CELLS | IN-VIVO | NITRIC-OXIDE | FACTOR EXPRESSION | VASCULAR-PERMEABILITY | DEFICIENT MICE | CONTACT ACTIVATION | HEMATOLOGY | FACTOR-XII | Epoprostenol - genetics | Receptor, Bradykinin B2 - genetics | Receptors, G-Protein-Coupled - metabolism | Epoprostenol - biosynthesis | Peptide Fragments - pharmacology | Carotid Artery Thrombosis - metabolism | Pyrones - pharmacology | Sirtuin 1 - genetics | Thromboplastin - antagonists & inhibitors | Nerve Tissue Proteins - biosynthesis | Synaptotagmins - biosynthesis | Carotid Artery Thrombosis - chemically induced | Prekallikrein | Thromboplastin - biosynthesis | Proto-Oncogene Proteins - metabolism | Kruppel-Like Transcription Factors - biosynthesis | Proto-Oncogene Proteins - antagonists & inhibitors | Angiotensin II - pharmacology | Receptor, Bradykinin B2 - biosynthesis | Sirtuin 1 - biosynthesis | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Sulfonamides - pharmacology | Nerve Tissue Proteins - genetics | Sirtuin 1 - antagonists & inhibitors | Mice, Knockout | Naphthalenes - pharmacology | Animals | Partial Thromboplastin Time | Thromboplastin - genetics | Receptors, G-Protein-Coupled - antagonists & inhibitors | Mice | Receptors, G-Protein-Coupled - genetics | Synaptotagmins - genetics | Carotid Artery Thrombosis - genetics | Carotid Artery Thrombosis - pathology | Kruppel-Like Transcription Factors - antagonists & inhibitors | Kruppel-Like Transcription Factors - genetics | RNA, Messenger | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis
Journal Article
The Journal of Nutritional Biochemistry, ISSN 0955-2863, 09/2012, Volume 23, Issue 9, pp. 1100 - 1112
Resveratrol is a natural polyphenolic compound with anti-inflammatory, antioxidant and neuroprotective properties, and it serves as a chemopreventive and... 
Silent information regulator 1 | AMP-activated protein kinase α | Protein kinase B | Survivin | Resveratrol | Apoptosis | Sirtuin 1 - metabolism | AMP-Activated Protein Kinases - metabolism | Caspase Inhibitors - pharmacology | Apoptosis - drug effects | Inhibitor of Apoptosis Proteins - genetics | Stilbenes - pharmacology | Membrane Potential, Mitochondrial - drug effects | Sirtuin 1 - genetics | Chromatin Assembly and Disassembly - drug effects | Repressor Proteins - antagonists & inhibitors | Adipocytes, White - ultrastructure | Adipocytes, White - drug effects | Caspases - metabolism | Inhibitor of Apoptosis Proteins - antagonists & inhibitors | Inhibitor of Apoptosis Proteins - metabolism | Caspases - chemistry | Proto-Oncogene Proteins c-akt - metabolism | Repressor Proteins - metabolism | Second Messenger Systems - drug effects | AMP-Activated Protein Kinases - antagonists & inhibitors | Gene Silencing | Repressor Proteins - genetics | Antioxidants - pharmacology | 3T3-L1 Cells | Down-Regulation - drug effects | Sirtuin 1 - antagonists & inhibitors | Up-Regulation - drug effects | Animals | Mice | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering | S Phase - drug effects | AMP-Activated Protein Kinases - genetics | Adipocytes, White - metabolism | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Antioxidants | Cytochrome c | RNA | Adenylic acid | Cells | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 01/2015, Volume 34, Issue 2, pp. 188 - 198
Journal Article